Isabelle Hoorens (I Hoorens)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Ankylosing Spondylitis

Basal Cell Carcinoma

Disease Activity

Top Venues

JMIR dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

PharmacoEconomics

The Journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Annick Meertens, Laura Van Coile, Tijs Van Iseghem, Lieve Brochez, Nick Verhaeghe, Isabelle Hoorens
Cost-of-Illness of Skin Cancer: A Systematic Review. PharmacoEconomics (2024)
Sofie Mylle, Jorien Papeleu, Isabelle Hoorens, Evelien Verhaeghe, Lieve Brochez
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study. JMIR dermatology 7 (2024)
Sofie Mylle, Jorien Papeleu, Isabelle Hoorens, Evelien Verhaeghe, Lieve Brochez
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study. JMIR dermatology 7 (2024)
Sofie Mylle, Jorien Papeleu, Isabelle Hoorens, Evelien Verhaeghe, Lieve Brochez
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study. JMIR dermatology 7 (2024)
Sofie Mylle, Jorien Papeleu, Isabelle Hoorens, Evelien Verhaeghe, Lieve Brochez
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study. JMIR dermatology 7 (2024)
Annick Meertens, Laura Van Coile, Tijs Van Iseghem, Lieve Brochez, Nick Verhaeghe, Isabelle Hoorens
Cost-of-Illness of Skin Cancer: A Systematic Review. PharmacoEconomics 42 (7) (2024)
Annick Meertens, Laura Van Coile, Tijs Van Iseghem, Lieve Brochez, Nick Verhaeghe, Isabelle Hoorens
Cost-of-Illness of Skin Cancer: A Systematic Review. PharmacoEconomics 42 (7) (2024)
Jo Lydie Wilfried Lambert, Julien Lambert, Koen Roegies, Arjen Nikkels, Marjan Garmyn, Johan Snauwaert, Fabienne Willaert, Bernard Bouffioux, Isabelle Hoorens, Katrien Vossaert, Jan Gutermuth, Véronique Del Marmol
The doctor will see you now, in 4 months: A Belgian perspective on waiting times for dermatologic care. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Sofie Mylle, Jorien Papeleu, Isabelle Hoorens, Evelien Verhaeghe, Lieve Brochez
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study. JMIR dermatology 7 (2024)
Laura Van Coile, Evelien Verhaeghe, Katia Ongenae, Lieve Brochez, Isabelle Hoorens
Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting is appropriate? The British journal of dermatology 187 (2) (2022)
Niels Timo Hilhorst, Elfie Deprez, Deepak Mukesh Wieshwaykumar Balak, Nanja van Geel, Jan Gutermuth, Isabelle Hoorens, Jo Lydie Wilfried Lambert
Initiating value-based healthcare in psoriasis: Proposing a value-based outcome set for daily clinical practice. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Nanja van Geel, L Depaepe, V Vandaele, L Mertens, J Van Causenbroeck, S De Schepper, L Van Coile, A Van Reempts, A-S De Vos, J Papeleu, Isabelle Hoorens, D Mertens, A Wolkerstorfer, J E Lommerts, Speeckaert Reinhart
Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS). Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Isabelle Hoorens, R Waalboer-Spuij, L Van Coile, M Debaveye, A Shen, E Verhaeghe, L Brochez
Health state utility instruments in patients with keratinocyte cancer and actinic keratosis: a cross-sectional study. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Lieve Brochez, Reinhart Speeckaert, Dirk De Bacquer, Joris Delanghe, Isabelle Hoorens
Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case-control study. The Journal of dermatology 46 (3) (2019)